Drug giant Pfizer aims to buy Botox-maker Allergan in $160bn deal
US pharmaceuticals player Pfizer has agreed to buy Botox-maker Allergan for an estimated $160bn in a deal that will create the largest drug-maker in the world.
News & Analysis on Cosmetics Innovation
US pharmaceuticals player Pfizer has agreed to buy Botox-maker Allergan for an estimated $160bn in a deal that will create the largest drug-maker in the world.
Estée Lauder Companies has announced additional responsibilities for executive group president John Demsey, while also promoting Jane Hertzmark Hudis to group president.